Abbreviated CURRICULUM VITAE
Paul Strengers obtained his Medical Degree from the University of Leiden, The Netherlands. He started in organ transplantation at the Academic Medical Centre in Amsterdam. In 1986, he joined the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB). In 1992, a post-graduate coursein Transfusion Medicine was followed in Edinburgh, Scotland, and in Clinical Epidemiology at Leiden University. He was Medical Director of CLB Blood Bank (1999-2003), Medical Director at CAF-DCF in Brussels, Belgium (2000-2017), Director Medical Affairs and Product Development at Sanquin Blood Supply, Division of Plasma Products, in Amsterdam (2003-2015), and Advisor to the Board of Sanquin Plasma Products (2015-2017).
His research and activities in blood transfusion medicine are focused on clinical transfusion medicine and sciences i.a. haemophilia and inhibitors to factor VIII, coagulation and the reversal of anti-coagulant therapy, intravenous immunoglobulins and its indications, haemovigilance and pharmacovigilance, and blood transfusion quality, ethics and organization.
Currently, he is an independent consultant, specialized in blood and plasma.
In this capacity, he is Executive Director of the International Plasma and Fractionation Association on a freelance basis. Further he is a Member of the Expert Committee on Biological Standardization, section Blood, of the World Health Organization. He is Chairman of the Supervisory Board of the Netherlands’ Royal Tropical Institute (KIT), Fellow at the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians, UK, and member of international advisory boards, and international editorial boards of a number of scientific journals. He was President of the International Haemovigilance Network (2000-2006), Secretary-General of the International Society of Blood Transfusion (2000-2010), President of the International Plasma Fractionation Association (2012-2016) and Chairman of the Netherlands Red Cross, district of Amsterdam-Amstelland (2008-2018).
He is Honorary Member of the International Society of Blood Transfusion and Corresponding Member of the Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI).
Publications include author or co-author of more than 150 scientific papers.